12. American Chamber of Commerce in Korea. Healthcare as Korea's future engine of growth: AMCHAM Healthcare Innovation Seminar 2014. Session B: growth through open inno-vation and global collaboration between local and global medi-cal device manufacturers [Internet]. Seoul: American Chamber of Commerce in Korea;2014. cited 2015 Sep 29. Available from:
http://www.amchamkorea.org/publications/HC%20Seminar%202014/B/5_Woon_Yong_Kim.pdf.
15. Lee DH. After designation of research-driven hospitals. J Korean Med Assoc. 2014; 57:378–381.
Article
17. Smith SW, Sfekas A. How much do physician-entrepreneurs contribute to new medical devices. Med Care. 2013; 51:461–467.
Article
18. Chatterji AK, Fabrizio KR, Mitchell W, Schulman KA. Physi-cian-industry cooperation in the medical device industry. Health Aff (Millwood). 2008; 27:1532–1543.
Article
19. Xu S, Avorn J, Kesselheim AS. Origins of medical innovation: the case of coronary artery stents. Circ Cardiovasc Qual Outcomes. 2012; 5:743–749.
21. Special Act on Fostering and Support of Pharmaceutical Indu-stry. Pub. L. No. 10519. 2011. 03. 30.
24. Ministry of Health and Welfare. Criteria for the reimbursement decision and adjustment of medical procedures and medical devices, etc: pricing rule on maximum reimbursement prices of medical devices [Internet]. Sejong: Ministry of Health and Welfare;2014. cited 2015 Sep 29. Available from:
http://www.mw.go.kr/front_new/jb/sjb0406vw.jsp.
25. Hong SH. Medical device clinical trial. J Korean Med Assoc. 2010; 53:769–773.
Article
26. Lee SS. Medical technology development and globalization: the role of the medical device industry. J Korean Med Assoc. 2014; 57:919–926.
Article
27. Ministry of Health and Welfare. Notice letter 3639 from the Division of Health Insurance Benefits: the notice about reimbursement coverage of investigator-initiated clinical trial [Internet]. Sejong: Ministry of Health and Welfare;2015. cited 2015 Sep 29. Available from:
https://www.kha.or.kr/board/dept/view.